High parathyroid hormone rather than low vitamin D is associated with reduced event-free survival in childhood cancer.
Corinna GrasemannJakob HoeppnerWolfgang HöglerStephan TippeltMaximilian GrasemannDesiree GrabowGunnar CarioMartin ZimmermannMartin SchrappeDirk ReinhardtMichael M SchündelnPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
This study identifies elevated parathyroid hormone (PTH) as a potential marker for poor outcomes in pediatric cancer patients, emphasizing the need for adequate vitamin D and calcium management.